Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease
about
Mitochondrial permeability transition pore is a potential drug target for neurodegenerationInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.A proteomic approach to analyzing responses of Arabidopsis thaliana root cells to different gravitational conditions using an agravitropic mutant, pin2 and its wild type.Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobuleA novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseasesConvergence of amyloid-beta and tau pathologies on mitochondria in vivo.ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer.Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor.Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairmentA transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregationATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.Interaction of aldehydes derived from lipid peroxidation and membrane proteinsBrain site-specific proteome changes in aging-related dementia.Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?Lipid raft proteome reveals that oxidative phosphorylation system is associated with the plasma membrane.Oxidative stress and β-amyloid protein in Alzheimer's disease.Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of ageDevelopment and characterization of mitochondrial membrane affinity chromatography columns derived from skeletal muscle and platelets for the study of mitochondrial transmembrane proteins.Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.A therapeutic connection between dietary phytochemicals and ATP synthase.Tau aggregation and toxicity in a cell culture model of tauopathy.Amyloid-like Fibrils from an α-Helical Transmembrane Protein.Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation.Age-associated oxidative modifications of mitochondrial α-subunit of F1 ATP synthase from mouse skeletal muscles.mPOS is a novel mitochondrial trigger of cell death - implications for neurodegeneration.β-amyloid peptide binds and regulates ectopic ATP synthase α-chain on neural surface.ATP synthase: the right size base model for nanomotors in nanomedicine.Characterization of Myelin Sheath F(o)F(1)-ATP synthase and its regulation by IF(1).
P2860
Q27023850-DC62A5FC-781F-4A7E-9FB0-AB090CE21E98Q28076999-22DBC284-5714-4CFA-A9CF-DFA460CC741EQ30446460-FA2985D0-87C0-4F6F-BB3F-D3AFFFBB3D6DQ30659873-DC0677B4-A2A5-45E0-BF12-AAF2BF9E45D6Q33352534-C0D7E3D5-2206-4420-ABA7-86E39C0CB7DEQ33643522-A7610E8E-2C95-4135-BDE1-5B16FA8C7EF6Q33851008-351D2C06-22E8-456B-BF48-5F579C6E49ACQ33876147-56C79FF3-1E44-42A4-82DF-6576C1D4FD9FQ34094912-FBFEE27D-DE4E-4AC3-9777-69F4F066F598Q34428768-699D96DD-1F3A-45B2-9238-423EBE5BDDDCQ35781535-43FA931C-9C98-4579-A6CE-92154C695744Q36866261-FBB4B494-BB4B-4D26-B8CC-4E5646EF40A3Q36995302-CC7BAE71-904C-4355-A840-22F0593FB816Q37142547-D14B4FDE-CE7B-4DD9-BE94-A4ED2CB8B0D7Q37212178-94CB8F31-79D1-4E72-8302-471859D81D09Q37612356-69B7A064-FEF7-4DAE-AC06-4D4998B56286Q37818312-D6D2ABBE-B740-4BB1-809D-F6BED6FC83DEQ37928994-273FDB9D-A58B-4A3F-B75F-F79A52BD0C78Q38050263-2B9045E8-FF06-4914-B559-B767ED78BDA6Q38793564-D0C2D418-02C5-4D50-9C5A-9E76B8553A5FQ38801948-B1CF9899-125A-4282-8395-BFB423B279F9Q38930361-B665743E-E4A1-4CE5-B97E-93BC2E49948EQ40083367-CF40BED3-F1A8-452D-B5AA-0C40FC588EF8Q40146754-0BC40F30-2BAB-49D4-B6A3-60AEAF947A8BQ41008649-B65913AA-C07A-447D-BCE1-92715A6C4912Q41714460-6E5136F5-99EF-41A2-97B8-F8900AD3152BQ46756609-910BB951-A57D-4CB6-84B4-FCFDA62D9A58Q47579528-A4BDD95A-CC6E-4CB2-88F7-BBA7D659541CQ48765869-23D991DF-336C-4BC6-9E7B-2F21A823B1FDQ54372352-DB6E034C-DCED-4DC8-99BB-B12C49770B79Q54652516-0D4C2323-6380-41EC-BB7E-FE98A70A5DC9
P2860
Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Association of ATP synthase al ...... eration in Alzheimer's disease
@ast
Association of ATP synthase al ...... eration in Alzheimer's disease
@en
Association of ATP synthase al ...... eration in Alzheimer's disease
@nl
type
label
Association of ATP synthase al ...... eration in Alzheimer's disease
@ast
Association of ATP synthase al ...... eration in Alzheimer's disease
@en
Association of ATP synthase al ...... eration in Alzheimer's disease
@nl
prefLabel
Association of ATP synthase al ...... eration in Alzheimer's disease
@ast
Association of ATP synthase al ...... eration in Alzheimer's disease
@en
Association of ATP synthase al ...... eration in Alzheimer's disease
@nl
P2093
P50
P1433
P1476
Association of ATP synthase al ...... eration in Alzheimer's disease
@en
P2093
A Delacourte
J-C Michalski
M Galván-valencia
R Mena-López
P304
P356
10.1016/S0306-4522(02)00747-9
P407
P577
2003-01-01T00:00:00Z